Abstract

4069Background: There is an unmet need for predictive biomarkers of clinical outcomes in resectable gastric cancer (RGC) treated with perioperative chemotherapy. We have used targeted error correct...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
Gail Darling ... John Zalcberg
BMC cancer | VOL. 15
Gail Darling, et. al.Gail Darling ... John Zalcberg
21 Jul 2015
Anastomotic leak predicts diminished long-term survival after resection for gastric and esophageal cancer
Panagiotis Fikatas ... Benjamin Struecker
Surgery | VOL. 160
Panagiotis Fikatas, et. al.Panagiotis Fikatas ... Benjamin Struecker
08 Apr 2016
P-354 Association between tumor regression with tumor location and inflammatory biomarkers in patients with resectable gastric cancer and gastroesophageal junction cancer who underwent perioperative chemotherapy: Multicentric data from Peru
A Leon ... R Motta
Annals of Oncology | VOL. 31
A Leon, et. al.A Leon ... R Motta
01 Jul 2020
Role of Preoperative Radiation Therapy for Resectable Gastric Cancer.
Grace Lee ... Jennifer Y Wo
Journal of gastrointestinal cancer | VOL. -
Grace Lee, et. al.Grace Lee ... Jennifer Y Wo
14 Feb 2024
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers